A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response
Clinical trial NCT00623428 · COMPLETED
Trial details
- NCT number
- NCT00623428
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2012-05-01
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.